Judge Extends Block on Generic Wellbutrin

Law360, New York (December 15, 2003, 12:00 AM EST) -- The U.S. District Court for the Southern District of New York again extended the restraining order to prevent Eon Labs from introducing Bupropion, the generic equivalent of GlaxoSmithKline’s antidepressant Wellbutrin.

The restraining order, scheduled to expire Monday, was extended to Dec. 22., Eon Lab said in a statement.

Eon Lab said it expects a hearing this week on a similar restraining order against the release of Bupropion HCl, ER 100mg tablets issued by a Federal District Court for the Southern District of Florida.

Andrx Group filed...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.